Demaria, Sandra
Weill Cornell Medicine,
United States
2025 Rank: 63148
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2598 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 63148 | 70005 |
| Total Cites | 25891 | 28773 |
| H-index | 71 | 73 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 4452 | 4751 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 13186 | 14127 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15710 | 16659 |
| Ratio of Total Citations to Distinct Citing Papers | 1.65 | 1.73 |
| Self-Citation Percentage |
10.02%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2024 Rank: 65242
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2713 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65242 | 71719 |
| Total Cites | 22857 | 25516 |
| H-index | 67 | 69 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 4108 | 4396 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 11823 | 12738 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13718 | 14570 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.75 |
| Self-Citation Percentage |
10.42%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2023 Rank: 69998
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2895 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69998 | 74812 |
| Total Cites | 19361 | 21712 |
| H-index | 62 | 65 |
| Hm-index | 17 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 3692 | 3963 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 10234 | 11071 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11572 | 12329 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.76 |
| Self-Citation Percentage |
10.83%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2022 Rank: 71317
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2963 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71317 | 78959 |
| Total Cites | 15868 | 17914 |
| H-index | 59 | 60 |
| Hm-index | 17 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 3290 | 3549 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 8725 | 9508 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9373 | 10027 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.79 |
| Self-Citation Percentage |
11.42%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2021 Rank: 77372
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3177 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77372 | 86515 |
| Total Cites | 14311 | 16157 |
| H-index | 58 | 58 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 3056 | 3303 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 7970 | 8714 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8451 | 9045 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.79 |
| Self-Citation Percentage |
11.43%
|
|
Demaria, Sandra
Weill Cornell Medicine,
United States
2020 Rank: 90344
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3775 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90344 | 97200 |
| Total Cites | 10047 | 11511 |
| H-index | 49 | 52 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 2485 | 2714 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 5848 | 6477 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6042 | 6505 |
| Ratio of Total Citations to Distinct Citing Papers | 1.66 | 1.77 |
| Self-Citation Percentage |
12.72%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.